GCMG GCM Grosvenor
GCM Grosvenor earnings company data as of 1:01 PM ET 10/23
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 4 Nov | EPS | 0.18 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by GCMG's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $8.6M sold by 3 insiders outside a trading plan
- $1.6M sold by 1 insider under 10b5-1 plans
-
Pamela L Bentley CFOPlanned sale$629K 50,000 shares at $12.59 78% of stakeTraded Sep 15–16 Filed Sep 16
-
Kathleen Patricia Sullivan Principal Accounting OfficerSale$526K 40,000 shares at $13.16 47% of stakeTraded Sep 2–3 Filed Sep 3
-
Fitzgerald L. P. Cantor 10% owner, +4 joint filersSale$7.6M 557,106 shares at $13.63 8.6% of stakeTraded Jul 15–16 Filed Jul 17
-
Angela Blanton DirectorSale$489K 41,184 shares at $11.87 47% of stakeTraded Feb 26–27 Filed Feb 27
-
Pamela L Bentley CFOPlanned sale$929K 80,000 shares at $11.62 96% of stakeTraded Dec 16–17 Filed Dec 18, 2025
Also filed in the last 12 months, not counted as buying or selling: 21 option exercises, 9 share withholdings for taxes, 4 gifts, 3 stock grants, and 1 other transaction.
SEC filings
Recent issuer filings from EDGAR, 13 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.